2019
DOI: 10.1016/j.bpj.2018.11.2129
|View full text |Cite
|
Sign up to set email alerts
|

Role of the Cytoplasmatic M3-M4 Loop for the Homopentameric Assembly of a Chimeric Nicotinic Alpha 7 Receptor

Abstract: The FDA-approved drug bupropion has been prescribed as an antidepressant (Wellbutrin) for over three decades, and more recently as a smoking cessation aid (Zyban). The presumed mechanism of action of bupropion was inhibition of norephinephrine and dopamine reuptake by their respective transporters. Recently, bupropion's non-competitive antagonistic effect was demonstrated in nicotinic acetylcholine receptors (a1bεd, Torpedo, a1bgd, a3b4a55b2, a3b2, a4b2, a7) of the Cys-loop superfamily providing an alternate p… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles